Side effects are comparable, though AOD 9604 has more clinical data supporting its safety profile
Product Code : 2046
However, studies using beta-3-adrenergic receptor knockout mice revealed a more complex picture: Long-term AOD-9604 treatment failed to produce weight loss in beta-3-AR knockout mice Acute administration still increased energy expenditure and fat oxidation in knockout mice This suggests beta-3-AR expression enhancement contributes to, but does not directly mediate, lipolytic effects The peptide appears to work through an unidentified receptor mechanism that subsequently influences beta-3-adrenergic signaling pathways
[6] [7] For patients with neurological symptoms, hydroxocobalamin 1mg IM is given on alternate days until no further improvement, followed by maintenance injections of 1mg every two to three months
Hydroxycobalamin (nitric oxide scavenger) An excellent form to start supplementation with, well-tolerated, those patients that cannot tolerate methyl well do better on this form
Clinical observations show that users report thinking about food less frequently